The initial management of multiple myeloma in the era of novel agents: 2021 and beyond

被引：0
|
作者：
Nadeem, Omar [1 ]
Richardson, Paul G. [1 ]
机构：
[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Hematol Malignancies, Boston, MD USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 02期
关键词：
OPEN-LABEL; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; COMBINATION; MULTICENTER; CARFILZOMIB; DARATUMUMAB; PHASE-2;
D O I：
10.1111/bjh.17407
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 215
页数：3
相关论文
共 50 条
  • [41] Multiple Myeloma: New Surface Antigens for the Characterization of Plasma Cells in the Era of Novel Agents
    Muccio, Vittorio Emanuele
    Saraci, Elona
    Gilestro, Milena
    Gattei, Valter
    Zucchetto, Antonella
    Astolfi, Monica
    Ruggeri, Marina
    Marzanati, Eleonora
    Passera, Roberto
    Palumbo, Antonio
    Boccadoro, Mario
    Omede, Paola
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (01) : 81 - 90
  • [42] The Albumin and Monoclonal Protein Ratio as Prognostic Marker for Multiple Myeloma in the Era of Novel Agents
    Kadar, Katalin
    Wolf, Krisztina
    Tabori, Judit
    Karadi, Istvan
    Varkonyi, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (03) : 557 - 561
  • [43] Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
    Nucci, Marcio
    Anaissie, Elias
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1211 - 1225
  • [44] Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art
    Martino, Massimo
    Paviglianiti, Annalisa
    Memoli, Mara
    Martinelli, Giovanni
    Cerchione, Claudio
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [45] Depth of Response with Stem Cell Transplantation and Outcome for Multiple Myeloma in the Era of Novel Agents
    Dingli, David
    Gay, Francesca
    Buadi, Francis
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji
    Lacy, Martha Q.
    Russell, Stephen J.
    Rajkumar, Vincent
    Gertz, Morie
    BLOOD, 2009, 114 (22) : 506 - 506
  • [46] Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents.
    Giri, Smith
    Huntington, Scott F.
    Wang, Rong
    Zeidan, Amer Methqal
    Podoltsev, Nikolai Alexandrovich
    Gore, Steven
    Ma, Xiaomei
    Gross, Cary Philip
    Davidoff, Amy J.
    Neparidze, Natalia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Novel agents for multiple myeloma treatment
    Ribatti, Domenico
    Vacca, Angelo
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (06) : 395 - 395
  • [48] Novel agents for the treatment of multiple myeloma
    Palumbo, A.
    EJC SUPPLEMENTS, 2010, 8 (04): : 11 - 12
  • [49] Novel agents in the treatment of multiple myeloma
    Moreau, P.
    Hulin, C.
    ONCOLOGIE, 2010, 12 (5-6) : 353 - 361
  • [50] Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
    Podar, Klaus
    Leleu, Xavier
    CANCERS, 2021, 13 (20)
12345